Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. USO
2. DHR
3. NVDA
4. SPY
5. AMD
6. NOW
7. GM
8. SMCI
9. GOOGL
10. TSLA

Go back to Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
Pfizer Inc. (NYSE: PFE) Delayed: 24.82 -0.12 (0.48%)
Previous Close $24.94    52 Week High $37.39 
Open $25.18    52 Week Low $28.25 
Day High $25.19    P/E 15.04 
Day Low $24.78    EPS $1.65 
Volume 32,977,136